Addus HomeCare (NASDAQ:ADUS) Downgraded by Barclays

Barclays downgraded shares of Addus HomeCare (NASDAQ:ADUS) from an equal weight rating to an underweight rating in a report issued on Tuesday morning, Marketbeat Ratings reports. They currently have $83.00 price objective on the stock.

Several other analysts also recently issued reports on the company. Oppenheimer restated an outperform rating and issued a $118.00 price objective on shares of Addus HomeCare in a research report on Tuesday, March 26th. Royal Bank of Canada reissued an outperform rating and issued a $102.00 price target on shares of Addus HomeCare in a research note on Thursday, February 29th. Finally, William Blair reiterated an outperform rating on shares of Addus HomeCare in a report on Monday, February 5th. One equities research analyst has rated the stock with a sell rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and a consensus target price of $103.00.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $94.54 on Tuesday. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $1.53 billion, a P/E ratio of 24.62, a price-to-earnings-growth ratio of 1.88 and a beta of 0.96. The firm has a 50-day moving average price of $97.69 and a two-hundred day moving average price of $91.59. Addus HomeCare has a twelve month low of $77.30 and a twelve month high of $114.97.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, February 26th. The company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.17. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The business had revenue of $276.35 million during the quarter, compared to analysts’ expectations of $274.02 million. As a group, research analysts expect that Addus HomeCare will post 4.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently bought and sold shares of ADUS. AE Wealth Management LLC acquired a new stake in shares of Addus HomeCare during the third quarter worth approximately $469,000. SG Americas Securities LLC bought a new stake in shares of Addus HomeCare in the 3rd quarter worth about $532,000. Mach 1 Financial Group LLC acquired a new stake in shares of Addus HomeCare in the 3rd quarter valued at about $455,000. Exchange Traded Concepts LLC bought a new position in shares of Addus HomeCare during the third quarter worth about $1,209,000. Finally, Sheets Smith Wealth Management lifted its position in shares of Addus HomeCare by 2.5% during the third quarter. Sheets Smith Wealth Management now owns 6,892 shares of the company’s stock worth $587,000 after purchasing an additional 168 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.